- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01168661
Yoga, Mindfulness and Cognitive Psychotherapy as Treatment for Stress and Burnout
July 22, 2010 updated by: Karolinska Institutet
The purpose of this study is to investigate if treatment with yoga or mindfulness has a more profound and longstanding effect on stress and burnout than treatment with cognitive psychotherapy alone.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Huddinge
-
Stockholm, Huddinge, Sweden, 14183
- Karolinska Institutet
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- On sick leave at least 50% at the beginning of the study.
- Sick leave for a maximum of 1 year if on full-time sick leave at the beginning of the study or for a maximum of 3 years if on part-time sick leave at the beginning of the study.
- Speak Swedish well enough to participate in the study interventions.
- Body mass index (BMI) of between 18 and 30.
- Meet the diagnostic criteria for burnout syndrome from the Swedish National Board of Health and Welfare.
Exclusion Criteria:
- Medication, including all medication or topical skin preparations with cortisone in any form. Exceptions: Antidepressants, contraceptives, hormone replacement therapy for hypothyroidism if hormone levels were within the normal range, and hormone replacement therapy to treat menopausal symptoms. To receive an exception for medication, a participant had to take the same medication at the same dose at both blood tests.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control arm
Participants in this arm will be recruited from the group who applied to participate in the study and fulfilled the inclusion criteria but for various reasons (such as time constraints) could not participate.
|
|
Active Comparator: Cognitive psychotherapy arm
In this arm, participants will attend a group meeting to practice cognitive psychotherapy once a week.
They will also practice on their own >= 4 times a week.
|
Participants in this arm will attend a weekly group meeting to practice cognitive psychotherapy.
They will also practice >= 4 time a week on their own.
Additionally, participants in this arm will practice various practical skills, such as how to plan a satisfactory day using their own definition of a satisfactory day.
Participants will follow this schedule for 20 weeks.
|
Active Comparator: Mindfulness based cog psychotherapy arm
In this arm, participants will attend a group meeting to practice mindfulness based cognitive psychotherapy once a week.
They will also practice on their own >= 4 times a week.
|
Participants in this arm will attend a weekly group meeting to practice mindfulness based cognitive psychotherapy.
They will also practice >= 4 time a week on their own.
Additionally, participants in this arm will practice various practical skills, such as how to plan a satisfactory day using their own definition of a satisfactory day.
Participants will follow this schedule for 20 weeks.
|
Active Comparator: Yoga treatment group
Persons in this arm will practice yoga >= 5 time each week (2 times in a supervised group and the other times on their own).
|
Participants in this intervention arm will practice yoga (physical postures, breathing exercises, and meditation) >= 5 times a week (twice in a supervised group and the rest on their own).
Additionally, participants in this arm will practice various practical skills, such as how to plan a satisfactory day using their own definition of a satisfactory day.
They will follow this schedule for 20 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduced stress measured by qualitative questionnaires
Time Frame: 5 months after start of treatment
|
Level of stress will be measured by qualitiative questionnaries, including the Swedish Health-Related Quality of Life Survey (SWEQUAL).
|
5 months after start of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Reduced cortisol secretion
Time Frame: 5 months after start of treatment
|
We will measure cortisol level in a 24-hour sample of urine.
|
5 months after start of treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Astrid M Grensman, MD, Karolinska Institutet
- Principal Investigator: Bikash Dev Acharya, MSc Psyc, Karolinska Institutet
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2007
Primary Completion (Actual)
April 1, 2010
Study Completion (Actual)
April 1, 2010
Study Registration Dates
First Submitted
July 22, 2010
First Submitted That Met QC Criteria
July 22, 2010
First Posted (Estimate)
July 23, 2010
Study Record Updates
Last Update Posted (Estimate)
July 23, 2010
Last Update Submitted That Met QC Criteria
July 22, 2010
Last Verified
July 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pickup 2003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on Cognitive psychotherapy
-
Universidade Federal do Rio de JaneiroCompleted
-
University Hospital TuebingenCompletedPsychotherapy Intervention EvaluationGermany
-
University Hospital TuebingenUnknownPsychotherapy Intervention Evaluation
-
University Hospital FreiburgCompletedChronic Major Depressive DisorderGermany
-
Ministry of Health, MozambiqueColumbia UniversityCompleted
-
Copenhagen Trial Unit, Center for Clinical Intervention...Bispebjerg HospitalCompletedHypochondriasis
-
Universitätsklinikum Hamburg-EppendorfUniversity of BremenNot yet recruiting
-
Institut Català d'OncologiaCompletedEmotional Disorder | Breastcancer | DistressSpain